batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Time is running out for the NRF2 mechanism 13 November 2025 Kura gets a safety edge over Syndax 13 November 2025 Gilead fails outside triple negative 11 November 2025 UroGen's exit makes Agenus look smart 7 November 2025 Bad omens for BioNTech & Roche’s neoantigen project 5 November 2025 Incyte gets a Prelude insurance policy 5 November 2025 Pfizer’s PD-L1 conjugate focus narrows 4 November 2025 Bristol stops SOS1 4 November 2025 Load More